(3R,4R)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid

Catalog No. :
ACWCDQ065
CAS No. :
254101-11-6
Molecular Formula :
C17H25NO5
Molecular Weight :
323.39

IUPAC Name:(3R,4R)-4-(benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid

(3R,4R)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$67.00Login to see priceIn stockInquiry
5g95%$255.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4R)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid
IUPAC Name(3R,4R)-4-(benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid
MDL No.MFCD01862935
Molecular FormulaC17H25NO5
Molecular Weight323.39
SMILESC[C@@H](OCC1=CC=CC=C1)[C@@H](CC(O)=O)NC(OC(C)(C)C)=O
InChI KeyFYZBABHQLFFCHH-TZMCWYRMSA-N
SynonymCS-0199382 | MFCD01862935 | SCHEMBL16931255 | AKOS015900664 | DTXSID301117590 | Boc-L-beta-homothreonine(OBzl) | Boc-O-benzyl-L-beta-homothreonine | FYZBABHQLFFCHH-TZMCWYRMSA-N | AC-25443 | (3R,4R)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic aci
CAS No.254101-11-6
PubChem CID2761547

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWCDQ065 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWCDQ065 route product structure diagram
    ACWCDQ065254101-11-6 In Stock
Inquiry

2. ACWCDQ065 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCDQ065 route product structure diagram
    ACWCDQ065254101-11-6 In Stock
Inquiry

Comments (0)